tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market

Pharma Mar SA (PHMMF) Income Statement

Compare
58 Followers

Pharma Mar SA Income Statement

Last quarter (Q2 2025), Pharma Mar SA's total revenue was €56.39M, an increase of 31.54% from the same quarter last year. In Q2, Pharma Mar SA's net income was €23.37M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 174.85M€ 158.15M€ 196.34M€ 229.83M€ 269.96M
Gross Profit
€ 166.67M€ 148.54M€ 182.70M€ 213.39M€ 256.24M
Operating Expenses
€ 160.20M€ 152.37M€ 138.27M€ 121.04M€ 100.03M
Depreciation and Amortization
€ 6.77M€ 5.76M€ 5.90M€ 5.58M€ 7.21M
EBITDA
€ 21.23M€ 4.55M€ 52.07M€ 104.08M€ 155.94M
Operating Income
€ 6.47M€ -3.83M€ 44.07M€ 92.45M€ 155.94M
Other Income/Expenses
€ 5.52M€ 204.00K€ -281.00K€ -6.36M€ -10.34M
Pretax Income
€ 11.98M€ -3.62M€ 43.79M€ 95.13M€ 145.61M
Net Income
€ 26.13M€ 1.14M€ 49.36M€ 92.86M€ 137.26M
Per Share Metrics
Basic EPS
€ 1.48€ 0.06€ 2.73€ 5.14€ 7.50
Diluted EPS
€ 1.48€ 0.06€ 2.73€ 5.13€ 7.49
Weighted Average Shares Outstanding
17.54M 17.90M 18.05M 18.07M 18.29M
Weighted Average Shares Outstanding (Diluted)
17.56M 17.92M 18.06M 18.09M 18.32M
Currency in EUR

Pharma Mar SA Earnings and Revenue History